ALGEA (EGFF)
One of 3,761 projects Taiyo tracks in Austria.
Source: European Investment Bank (EIB)
The Company is a biopharmaceutical company developing therapeutic solutions for the treatment of respiratory and ophthalmic conditions. The eligible investment plan includes research and development (R&D) and related expenses to finance the development of the Company's two proprietary biotechnology platforms during the investment period 2019-2022.
- Status
- Prospective
- Sector
- Manufacturing (Industrial), Government
- Location
- Austria
- Updated
- 19 Nov 2026
- Source
- European Investment Bank (EIB)
ConstructChat
Ask ConstructChat about ALGEA (EGFF)
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | financed |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | The Company is a biopharmaceutical company developing therapeutic solutions for the treatment of respiratory and ophthalmic conditions. The eligible investment plan includes research and development (R&D) and related expenses to finance the development of the Company's two proprietary biotechnology platforms during the investment period 2019-2022. |
Original sector | Services |
Budget |
Location
Country | Austria |
Source
Source reliability | High |
Source | European Investment Bank (EIB) |
URL |
More Details
Record type | Project |
Sector | Manufacturing (Industrial), Government |
Article published date | 2023-05-08 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Manufacturing (Industrial) projects in Austria
- Reisseck II Pumped Storage Power Plant Carinthia
- Boehringer Ingelheim Biopharmaceutical Production
- AFFORDABLE PASSIVE HOUSE LIVING SPACE INNSBRUCK
- New digital communication channel for Cities
- Symptoma
- Drive-Through COVID-19 Community Testing
- Non-combustible laminate (DIN EN 438 HPL)
- Carbon2Product Austria (C2PAT)
